Abstract
In order to develop agonist ligands that are specific for the estrogen-related receptors ERRbeta/gamma, a hydrazone with a 4-hydroxy group at one phenyl ring and a 4-diethylamino moiety at the other phenyl ring was synthesized. We demonstrate that compound 3 (DY131; N'-{(1E)-[4-(diethylamino)phenyl]methylene}-4-hydroxybenzohydrazide) effectively and selectively activates ERRbeta/gamma. DY131 had no effect on the structurally related receptors ERRalpha or the estrogen receptors alpha and beta (ERalpha/beta). This work defines a convenient synthesis for a novel and selective pharmacologic tool that can be used to elucidate the biological activities of ERRbeta/gamma.
MeSH terms
-
Animals
-
Cell Line
-
Dose-Response Relationship, Drug
-
Drug Evaluation, Preclinical
-
ERRalpha Estrogen-Related Receptor
-
Humans
-
Hydrazines / chemical synthesis*
-
Hydrazines / chemistry
-
Hydrazines / pharmacology
-
Hydrazones / chemical synthesis*
-
Hydrazones / chemistry
-
Hydrazones / pharmacology
-
Ligands
-
Mice
-
Molecular Mimicry
-
Molecular Structure
-
Receptors, Cytoplasmic and Nuclear / agonists*
-
Receptors, Cytoplasmic and Nuclear / genetics
-
Receptors, Cytoplasmic and Nuclear / physiology
-
Receptors, Estrogen / agonists*
-
Receptors, Estrogen / genetics
-
Receptors, Estrogen / physiology
-
Structure-Activity Relationship
-
Transfection
Substances
-
Hydrazines
-
Hydrazones
-
Ligands
-
Receptors, Cytoplasmic and Nuclear
-
Receptors, Estrogen
-
ERRalpha Estrogen-Related Receptor
-
ESRRB protein, human
-
Esrrg protein, mouse
-
N'-((1E)-(4-(diethylamino)phenyl)methylene)-4-hydroxybenzohydrazide